All EDQM press releases
Pharmacopoeial discussion group achievements
The meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP), and United States Pharmacopeia (USP)] was hosted by JP in Tokyo, Japan, 24-26 October 2016.
European Pharmacopoeia prepares for the future through exchange with stakeholders
To mark the publication of the 9th edition of the European Pharmacopoeia (Ph. Eur.), the EDQM organised a large international conference in Tallinn (Estonia), which brought together representatives of European and international regulatory authorities, the World Health Organization (WHO),...
155th Session of the European Pharmacopoeia Commission
Following the election of its Chair, Dr Tobias Gosdschan, in its March session, the European Pharmacopoeia (Ph. Eur.) Commission elected Prof. Torbjörn Arvidsson (Sweden) and Dr Hilda Köszegi Szalai (Hungary) as its first and second Vice-chair, respectively, for a term of three years.
European Pharmacopoeia Commission adopts revised general chapter on Monocyte-activation test to facilitate reduction in testing on laboratory animals
During its 155th Session, held in Strasbourg on 21-22 June 2016, the European Pharmacopoeia (Ph. Eur.) Commission adopted a revision of the general chapter Monocyteactivation test (2.6.30) in order to make it more widely useable by stakeholders and thus facilitate a reduction in testing on...
Pharmacopoeial Discussion Group Achievements
The meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph.Eur.), Japanese Pharmacopoeia (JP), and the United States Pharmacopeia (USP)] was hosted by EDQM in Strasbourg, France, 25-26 May 2016.
